UCB Beheer
Beheer criteriumcontroles 3/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Jean-Christophe Tellier
Algemeen directeur
€6.7m
Totale compensatie
Percentage CEO-salaris | 19.4% |
Dienstverband CEO | 9.8yrs |
Eigendom CEO | n/a |
Management gemiddelde ambtstermijn | 5yrs |
Gemiddelde ambtstermijn bestuur | 10.6yrs |
Recente managementupdates
Recent updates
Why We're Not Concerned About UCB SA's (EBR:UCB) Share Price
Oct 22These 4 Measures Indicate That UCB (EBR:UCB) Is Using Debt Reasonably Well
Sep 10Analysts Have Made A Financial Statement On UCB SA's (EBR:UCB) Half-Yearly Report
Jul 28Investors Still Waiting For A Pull Back In UCB SA (EBR:UCB)
Jul 15Shareholders Will Probably Not Have Any Issues With UCB SA's (EBR:UCB) CEO Compensation
Apr 19Is UCB (EBR:UCB) A Risky Investment?
Mar 27Earnings Tell The Story For UCB SA (EBR:UCB) As Its Stock Soars 26%
Mar 04UCB SA's (EBR:UCB) P/E Is On The Mark
Dec 28UCB (EBR:UCB) Takes On Some Risk With Its Use Of Debt
Nov 12Is UCB (EBR:UCB) Using Too Much Debt?
Aug 07Are Investors Undervaluing UCB SA (EBR:UCB) By 48%?
Jun 02UCB's (EBR:UCB) Upcoming Dividend Will Be Larger Than Last Year's
Apr 05Does UCB (EBR:UCB) Have A Healthy Balance Sheet?
Apr 03Here's Why UCB (EBR:UCB) Can Manage Its Debt Responsibly
Dec 05These 4 Measures Indicate That UCB (EBR:UCB) Is Using Debt Reasonably Well
Sep 05Does UCB (EBR:UCB) Have A Healthy Balance Sheet?
Jun 06UCB (EBR:UCB) Is Paying Out A Larger Dividend Than Last Year
Apr 23UCB's (EBR:UCB) Upcoming Dividend Will Be Larger Than Last Year's
Apr 09UCB (EBR:UCB) Has Announced That It Will Be Increasing Its Dividend To €0.91
Mar 26Here's Why UCB (EBR:UCB) Can Manage Its Debt Responsibly
Dec 23Are Investors Undervaluing UCB SA (EBR:UCB) By 42%?
Dec 05Here's Why UCB (EBR:UCB) Can Manage Its Debt Responsibly
Sep 23UCB SA (EBR:UCB) Shares Could Be 44% Below Their Intrinsic Value Estimate
Sep 05UCB SA Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Jul 31Is UCB (EBR:UCB) A Risky Investment?
Jun 21UCB SA's (EBR:UCB) Intrinsic Value Is Potentially 96% Above Its Share Price
May 13Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Jun 30 2024 | n/a | n/a | €240m |
Mar 31 2024 | n/a | n/a | €292m |
Dec 31 2023 | €7m | €1m | €343m |
Jun 30 2023 | n/a | n/a | €332m |
Mar 31 2023 | n/a | n/a | €376m |
Dec 31 2022 | €6m | €1m | €420m |
Jun 30 2022 | n/a | n/a | €887m |
Mar 31 2022 | n/a | n/a | €971m |
Dec 31 2021 | €6m | €1m | €1b |
Sep 30 2021 | n/a | n/a | €996m |
Jun 30 2021 | n/a | n/a | €936m |
Mar 31 2021 | n/a | n/a | €834m |
Dec 31 2020 | €7m | €1m | €732m |
Jun 30 2020 | n/a | n/a | €743m |
Mar 31 2020 | n/a | n/a | €767m |
Dec 31 2019 | €87k | n/a | €790m |
Jun 30 2019 | n/a | n/a | €652m |
Mar 31 2019 | n/a | n/a | €722m |
Dec 31 2018 | n/a | n/a | €792m |
Jun 30 2018 | n/a | n/a | €872m |
Mar 31 2018 | n/a | n/a | €812m |
Dec 31 2017 | €76k | n/a | €752m |
Compensatie versus markt: De totale vergoeding ($USD 6.98M ) Jean-Christophe } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Belgian markt ($USD 3.30M ).
Compensatie versus inkomsten: De vergoeding van Jean-Christophe is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Jean-Christophe Tellier (65 yo)
9.8yrs
Tenure
€6,662,655
Compensatie
Dr. Jean-Christophe Tellier serves as Executive Vice President and President of European Operations at Ucb S.A. Dr. Tellier served as President and General manager of North American operations at Ipsen S.A...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
CEO & Executive Director | 9.8yrs | €6.66m | geen gegevens | |
Executive VP | 4.3yrs | geen gegevens | geen gegevens | |
Executive Vice President of Supply & Technology Solutions | 5.2yrs | geen gegevens | geen gegevens | |
Executive VP & General Counsel | 1.6yrs | geen gegevens | geen gegevens | |
Executive VP & Chief Human Resources Officer | 4.8yrs | geen gegevens | geen gegevens | |
Executive VP & Chief Commercial Officer | 9.8yrs | geen gegevens | geen gegevens | |
Executive Vice President of Patient Evidence | less than a year | €164.00k | geen gegevens | |
Chief Accounting Officer | 11.7yrs | geen gegevens | geen gegevens | |
Executive VP & Chief Scientific Officer | less than a year | geen gegevens | geen gegevens | |
Head of Investor Relations | 14.8yrs | geen gegevens | geen gegevens | |
Head of Global Communication | no data | geen gegevens | geen gegevens | |
Head of Sustainability | no data | geen gegevens | geen gegevens |
5.0yrs
Gemiddelde duur
57.5yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van UCB wordt beschouwd als ervaren (gemiddelde ambtstermijn 5 jaar).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
CEO & Executive Director | 10.6yrs | €6.66m | geen gegevens | |
Honorary Chairman | no data | €70.00k | geen gegevens | |
Honorary Chairman | 19.8yrs | €15.50k | geen gegevens | |
Honorary Deputy Chairman | no data | €28.50k | geen gegevens | |
Honorary Chairman | no data | €30.00k | geen gegevens | |
Honorary Chairman | 3.6yrs | €87.50k | geen gegevens | |
Honorary Chairman | no data | €49.00k | geen gegevens | |
Independent Director | 10.6yrs | €138.00k | geen gegevens | |
Independent Chair of the Board | 3.6yrs | €341.83k | geen gegevens | |
Director | 12.6yrs | €108.50k | geen gegevens | |
Director | 10.6yrs | €86.00k | geen gegevens | |
Independent Director | less than a year | geen gegevens | geen gegevens |
10.6yrs
Gemiddelde duur
73yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van UCB zijn ervaren en ervaren (gemiddelde ambtstermijn van 10.6 jaar).